US FDA Shows Support For Generic Drug User Fee Goals Amid Cutbacks

Arrows hitting targets
The FDA's Office of Generic Drugs understands the importance of hitting user fee goal dates. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from Biosimilars & Generics